Study into medication known as ‘King Kong’ of weight loss drugs throws fresh light on effects of longer-term use
People who use the drug Mounjaro are able to sustain weight loss for three years, data from a trial suggests.
Mounjaro, nicknamed the “King Kong” of weight loss drugs, contains tirzepatide and is self-administered in once-a-week injections.
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
Australia has ‘no alternative’ but to embrace AI and seek to be a world leader in the field, industry and science minister says
European journalists targeted with Paragon Solutions spyware, say researchers